Therapeutic options for vancomycin-resistant enterococcal bacteremia
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Therapeutic options for vancomycin-resistant enterococcal bacteremia
Authors
Keywords
-
Journal
Expert Review of Anti-Infective Therapy
Volume 13, Issue 3, Pages 363-377
Publisher
Informa UK Limited
Online
2015-02-07
DOI
10.1586/14787210.2015.1001839
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Identification of temporal clusters and risk factors of bacteremia by nosocomial vancomycin-resistant enterococci
- (2014) Natal Santos da Silva et al. AMERICAN JOURNAL OF INFECTION CONTROL
- MRSA and VRE Colonization in Solid Organ Transplantation: A Meta-Analysis of Published Studies
- (2014) P. D. Ziakas et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Vancomycin-Resistant Enterococcal Bacteremia Pharmacotherapy
- (2014) Ruchi Patel et al. ANNALS OF PHARMACOTHERAPY
- Impact of Different Antimicrobial Therapies on Clinical and Fiscal Outcomes of Patients with Bacteremia Due to Vancomycin-Resistant Enterococci
- (2014) Kayoko Hayakawa et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacokinetics of Tedizolid in Subjects with Renal or Hepatic Impairment
- (2014) S. Flanagan et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Daptomycin activity tested against 164457 bacterial isolates from hospitalised patients: Summary of 8 years of a Worldwide Surveillance Programme (2005–2012)
- (2014) Helio S. Sader et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Incidence, Risk Factors, and Outcomes for Enterococcus spp. Blood Stream Infections: A Population-Based Study
- (2014) E.O. Billington et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Evaluation of the novel combination of daptomycin plus ceftriaxone against vancomycin-resistant enterococci in an in vitro pharmacokinetic/pharmacodynamic simulated endocardial vegetation model
- (2014) A. Hall Snyder et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Cardiolipin Prevents Membrane Translocation and Permeabilization by Daptomycin
- (2014) TianHua Zhang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Vancomycin-ResistantEnterococcus faecium(VRE) Bacteremia in Infective Endocarditis Successfully Treated with Combination Daptomycin and Tigecycline
- (2014) M. Polidori et al. JOURNAL OF CHEMOTHERAPY
- Once-Weekly Dalbavancin versus Daily Conventional Therapy for Skin Infection
- (2014) Helen W. Boucher et al. NEW ENGLAND JOURNAL OF MEDICINE
- Use of linezolid susceptibility test results as a surrogate for the susceptibility of Gram-positive pathogens to tedizolid, a novel oxazolidinone
- (2014) Gary Zurenko et al. Annals of Clinical Microbiology and Antimicrobials
- Summary of Linezolid Activity and Resistance Mechanisms Detected during the 2012 LEADER Surveillance Program for the United States
- (2013) Rodrigo E. Mendes et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Systematic Review and Meta-Analysis of Linezolid versus Daptomycin for Treatment of Vancomycin-Resistant Enterococcal Bacteremia
- (2013) Eleni P. Balli et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Systematic Review and Meta-Analysis of Linezolid and Daptomycin for Treatment of Vancomycin-Resistant Enterococcal Bloodstream Infections
- (2013) Donald W. Whang et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Genetic Basis forIn VitroandIn VivoResistance to Lincosamides, Streptogramins A, and Pleuromutilins (LSAP Phenotype) in Enterococcus faecium
- (2013) Christophe Isnard et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Multicenter Study of High-Dose Daptomycin for Treatment of Enterococcal Infections
- (2013) Anthony M. Casapao et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Ceftaroline Restores Daptomycin Activity against Daptomycin-Nonsusceptible Vancomycin-Resistant Enterococcus faecium
- (2013) George Sakoulas et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Treatment of High-Level Gentamicin-Resistant Enterococcus faecalis Endocarditis with Daptomycin plus Ceftaroline
- (2013) George Sakoulas et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Update of dalbavancin spectrum and potency in the USA: report from the SENTRY Antimicrobial Surveillance Program (2011)
- (2013) Ronald N. Jones et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Antibiotic consumption and resistance: Data from Europe and Germany
- (2013) Elisabeth Meyer et al. INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY
- Tedizolid Phosphate vs Linezolid for Treatment of Acute Bacterial Skin and Skin Structure Infections
- (2013) Philippe Prokocimer et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Impact of telavancin on prothrombin time and activated partial thromboplastin time as determined using point-of-care coagulometers
- (2013) Michael P. Ero et al. JOURNAL OF THROMBOSIS AND THROMBOLYSIS
- Epidemiology of Multidrug-Resistant Microorganisms among Nursing Home Residents in Belgium
- (2013) Béatrice Jans et al. PLoS One
- Risk factors associated with linezolid-nonsusceptible enterococcal infections
- (2012) Jessina C. McGregor et al. AMERICAN JOURNAL OF INFECTION CONTROL
- Evaluation of Standard- and High-Dose Daptomycin versus Linezolid against Vancomycin-Resistant Enterococcus Isolates in anIn VitroPharmacokinetic/Pharmacodynamic Model with Simulated Endocardial Vegetations
- (2012) Ashley D. Hall et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Combination Therapy with Ampicillin and Daptomycin for Treatment of Enterococcus faecalis Endocarditis
- (2012) M. Sierra-Hoffman et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Telavancin Pharmacokinetics and Pharmacodynamics in Patients with Complicated Skin and Skin Structure Infections and Various Degrees of Renal Function
- (2012) T. P. Lodise et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Fosfomycin SynergyIn Vitrowith Amoxicillin, Daptomycin, and Linezolid against Vancomycin-Resistant Enterococcus faecium from Renal Transplant Patients with Infected Urinary Stents
- (2012) Jillian L. Descourouez et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Epidemiology of Vancomycin-Resistant Enterococci with Reduced Susceptibility to Daptomycin
- (2012) Theresa Judge et al. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
- Antimicrobial-Resistant Pathogens Associated with Healthcare-Associated Infections Summary of Data Reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009–2010
- (2012) Dawn M. Sievert et al. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
- Activity of oritavancin against methicillin-resistant staphylococci, vancomycin-resistant enterococci and -haemolytic streptococci collected from western European countries in 2011
- (2012) I. Morrissey et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Twenty-five years of shared life with vancomycin-resistant enterococci: is it time to divorce?
- (2012) V. Cattoir et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Galleria mellonella as aModel for Studying Enterococcus faecium Host Persistence
- (2012) François Lebreton et al. JOURNAL OF MOLECULAR MICROBIOLOGY AND BIOTECHNOLOGY
- The rise of the Enterococcus: beyond vancomycin resistance
- (2012) Cesar A. Arias et al. NATURE REVIEWS MICROBIOLOGY
- Genetic Basis for Daptomycin Resistance in Enterococci
- (2011) Kelli L. Palmer et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Ampicillin Enhances Daptomycin- and Cationic Host Defense Peptide-Mediated Killing of Ampicillin- and Vancomycin-Resistant Enterococcus faecium
- (2011) George Sakoulas et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Oligomerization of daptomycin on membranes
- (2011) Jawad K. Muraih et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
- Use of Antistaphylococcal -Lactams to Increase Daptomycin Activity in Eradicating Persistent Bacteremia Due to Methicillin-Resistant Staphylococcus aureus: Role of Enhanced Daptomycin Binding
- (2011) A. Dhand et al. CLINICAL INFECTIOUS DISEASES
- High-density fecal Enterococcus faecium colonization in hospitalized patients is associated with the presence of the polyclonal subcluster CC17
- (2011) P. Ruiz-Garbajosa et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Emergence of Daptomycin-Resistant VRE: Experience of a Single Institution
- (2011) Mini Kamboj et al. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
- In vitro activity of tedizolid (TR-700) against linezolid-resistant staphylococci
- (2011) I. Rodriguez-Avial et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Vancomycin-resistant enterococcal bacteraemia and daptomycin: are higher doses necessary?
- (2011) E. A. King et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Successful therapy of treatment-emergent, non-clonal daptomycin-non-susceptible Enterococcus faecium infections
- (2011) S. T. King et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Genetic Basis for In Vivo Daptomycin Resistance in Enterococci
- (2011) Cesar A. Arias et al. NEW ENGLAND JOURNAL OF MEDICINE
- High-Dose Daptomycin for Treatment of Complicated Gram-Positive Infections: A Large, Multicenter, Retrospective Study
- (2011) Ravina Kullar et al. PHARMACOTHERAPY
- Comparative In Vitro Antimicrobial Activities of Torezolid (TR-700), the Active Moiety of a New Oxazolidinone, Torezolid Phosphate (TR-701), Determination of Tentative Disk Diffusion Interpretive Criteria, and Quality Control Ranges
- (2010) S. D. Brown et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Daptomycin Nonsusceptible Enterococci: An Emerging Challenge for Clinicians
- (2010) T. Kelesidis et al. CLINICAL INFECTIOUS DISEASES
- Telavancin versus Vancomycin for Hospital-Acquired Pneumonia due to Gram-positive Pathogens
- (2010) E. Rubinstein et al. CLINICAL INFECTIOUS DISEASES
- Comparison of outcomes from daptomycin or linezolid treatment for vancomycin-resistant enterococcal bloodstream infection: A retrospective, multicenter, cohort study
- (2010) Christopher W. Crank et al. CLINICAL THERAPEUTICS
- Worldwide summary of telavancin spectrum and potency against Gram-positive pathogens: 2007 to 2008 surveillance results
- (2010) Shannon D. Putnam et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Observational study of the epidemiology and outcomes of vancomycin-resistant Enterococcus bacteraemia treated with newer antimicrobial agents
- (2010) J. A. McKINNELL et al. EPIDEMIOLOGY AND INFECTION
- Outcomes of therapy: vancomycin-resistant enterococcal bacteremia in hematology and bone marrow transplant patients
- (2010) Shawna Kraft et al. SUPPORTIVE CARE IN CANCER
- Treatment of Resistant Enterococcal Urinary Tract Infections
- (2010) Subramanian Swaminathan et al. Current Infectious Disease Reports
- Multidrug-Resistant Enterococcus faecium Endocarditis Treated with Combination Tigecycline and High-Dose Daptomycin
- (2009) Amanda C Schutt et al. ANNALS OF PHARMACOTHERAPY
- In Vitro Activity of TR-700, the Active Ingredient of the Antibacterial Prodrug TR-701, a Novel Oxazolidinone Antibacterial Agent
- (2009) R. Schaadt et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Oritavancin Population Pharmacokinetics in Healthy Subjects and Patients with Complicated Skin and Skin Structure Infections or Bacteremia
- (2009) C. M. Rubino et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Activities of Dalbavancin against a Worldwide Collection of 81,673 Gram-Positive Bacterial Isolates
- (2009) D. J. Biedenbach et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In vitro antibacterial activity of tigecycline against resistant Gram-negative bacilli and enterococci by time–kill assay
- (2009) George A. Pankey et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Effectiveness of low-dose daptomycin in the treatment of vancomycin-resistant enterococcal urinary tract infections
- (2009) Larry Fisher et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Daptomycin for the treatment of enterococcal bacteraemia: results from the Cubicin® Outcomes Registry and Experience (CORE)
- (2009) John F. Mohr et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Vancomycin-resistant enterococcal bacteraemia: is daptomycin as effective as linezolid?
- (2009) V. Mave et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Activity of oxazolidinone TR-700 against linezolid-susceptible and -resistant staphylococci and enterococci
- (2009) D. M. Livermore et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Pharmacokinetics of Dalbavancin in Patients With Renal or Hepatic Impairment
- (2009) Thomas Marbury et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Vancomycin and Oritavancin Have Different Modes of Action in Enterococcus faecium
- (2009) Gary J. Patti et al. JOURNAL OF MOLECULAR BIOLOGY
- Daptomycin Therapy for Vancomycin-Resistant Enterococcal Bacteremia: A Retrospective Case Series of 30 Patients
- (2009) Jason C Gallagher et al. PHARMACOTHERAPY
- Lack of Effect of Moderate Hepatic Impairment on the Pharmacokinetics of Telavancin
- (2009) Michael R Goldberg et al. PHARMACOTHERAPY
- In Vitro Activity of TR-700, the Antibacterial Moiety of the Prodrug TR-701, against Linezolid-Resistant Strains
- (2008) K. J. Shaw et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Oritavancin Kills Stationary-Phase and Biofilm Staphylococcus aureus Cells In Vitro
- (2008) A. Belley et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Telavancin Versus Vancomycin for the Treatment of Complicated Skin and Skin‐Structure Infections Caused by Gram‐Positive Organisms
- (2008) Martin E. Stryjewski et al. CLINICAL INFECTIOUS DISEASES
- Antimicrobial-Resistant Pathogens Associated With Healthcare-Associated Infections: Annual Summary of Data Reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006–2007
- (2008) Alicia I. Hidron et al. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
- Risk of Vancomycin-Resistant Enterococcus (VRE) Bloodstream Infection Among Patients Colonized With VRE
- (2008) Chamion N. Olivier et al. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
- High acquisition and environmental contamination rates of CC17 ampicillin-resistant Enterococcus faecium in a Dutch hospital
- (2008) M. J. A. de Regt et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Oritavancin Exhibits Dual Mode of Action to Inhibit Cell-Wall Biosynthesis in Staphylococcus aureus
- (2008) Sung Joon Kim et al. JOURNAL OF MOLECULAR BIOLOGY
- Persistent vancomycin and high-level gentamicin-resistant Enterococcus faecium bacteremia and intra-aortic thrombus in an extremely low birth-weight infant
- (2008) N Hapnes et al. Journal of Perinatology
- Impact of the More-Potent Antibiotics Quinupristin-Dalfopristin and Linezolid on Outcome Measure of Patients with Vancomycin-Resistant Enterococcus Bacteremia
- (2007) K. M. Erlandson et al. CLINICAL INFECTIOUS DISEASES
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started